SEC Form 4 · accession 0001209191-15-083598
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin E Cearnal
Officer — Sr VP/Chief Commercial Officer · Director
Period of report
Dec 2, 2015
Accepted (ET)
Dec 4, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 2, 2015 | A | 1,950 | $5.58 | A | 131,856 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on November 19, 2019.